Stay updated with breaking news from Full Year. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lead program, Berubicin, successfully passed pre-planned interim futility analysis milestone with recommendation from DSMB to proceed without modification in potentially pivotal GBM studyBerubicin study enrollment completed; Topline data expected in first half of 2025Clinical progress represents important steps towa...
Leafly Holdings, Inc. beats earnings expectations. Reported EPS is $-0.22, expectations were $-1.41. Leafly Holdings, Inc.
- 2023 Revenue Increased 6% Year-Over-Year, with a 39% Increase in Full-Year Cannabinoid Revenue - - Drove Year-over-Year General and Administrative Expense Reductions of 26% in Q4 2023 and 24% for the Full Year - - Completed Sale of Non-Cannabinoid Herbal Brands Business on March 21, 2024 for $8.02 Million, Including $7.02 Million in Cash Paid at Closing - TOCANCIPÁ, Colombia, April 01, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”)
CULVER CITY, Calif., April 01, 2024 -- Snail, Inc. , a leading, global independent developer and publisher of interactive digital entertainment, today announced financial results for its fourth...
Forian Inc. beats earnings expectations. Reported EPS is $0.04, expectations were $0.012.